Search research articles
Contact Us
Filters
Showing results (231-240 of 280) with videos related to
Page
of 28
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials
Zobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
American Journal of Preventive Medicine
|
June 28, 2023
Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis
Pilar Hernandez-Con, Debbie L Wilson, Huilin Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 27, 2025
Global Burden of Chronic Liver Disease and Temporal Trends: A Population-Based Analysis From 1990 to 2021 With Projections to 2050
Yunyu Zhao, Yajing Bo, Jian Zu, et al.
JAMA Network Open
|
September 16, 2021
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis
Zobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Journal of Hepatology
|
April 11, 2023
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
Michael H Le, David M Le, Thomas C Baez, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
Journal of Viral Hepatitis
|
July 6, 2018
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
The Journal of Infectious Diseases
|
June 12, 2020
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
An K Le, Hwai-I Yang, Ming-Lun Yeh, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 280) with videos related to
Sort By:
Page
of 28
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials
Zobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
American Journal of Preventive Medicine
|
June 28, 2023
Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis
Pilar Hernandez-Con, Debbie L Wilson, Huilin Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 27, 2025
Global Burden of Chronic Liver Disease and Temporal Trends: A Population-Based Analysis From 1990 to 2021 With Projections to 2050
Yunyu Zhao, Yajing Bo, Jian Zu, et al.
JAMA Network Open
|
September 16, 2021
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis
Zobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Journal of Hepatology
|
April 11, 2023
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
Michael H Le, David M Le, Thomas C Baez, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
Journal of Viral Hepatitis
|
July 6, 2018
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
The Journal of Infectious Diseases
|
June 12, 2020
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
An K Le, Hwai-I Yang, Ming-Lun Yeh, et al.
Page
of 28